Skip to main content
Top
Published in: Pituitary 3/2013

01-09-2013

Evaluation of depression, quality of life and body image in patients with Cushing’s disease

Authors: Nilufer Alcalar, Sedat Ozkan, Pinar Kadioglu, Ozlem Celik, Penbe Cagatay, Baris Kucukyuruk, Nurperi Gazioglu

Published in: Pituitary | Issue 3/2013

Login to get access

Abstract

The aim of this study was to evaluate patients with Cushing’s disease (CD) who had undergone transsphenoidal surgery in terms of depression, quality of life (QoL), and perception of body image in comparison to healthy controls. Forty patients with CD and 40 healthy controls matched for demographic characteristics were included in the study. The subjects were evaluated with the Beck depression inventory (BDI), the health survey-short form (SF-36) and the multidimensional body-self relations questionnaire (MBSRQ). Subgroups of the patients with CD were formed on the basis of remission status and BDI scores. In this study, QoL in the general health category and body image were lower in the patients with CD than in the healthy subjects. However, no differences in depression scores were found between the two groups. When the CD group was evaluated according to remission rate, the mean BDI score was significantly higher in the CD patients without remission than in both the CD patients with remission and the healthy subjects (p = 0.04). However, the physical functioning, bodily pain and general health scores of the CD patients without remission on the SF-36 questionnaire were lower than in the CD patients in remission and the healthy subjects (p = 0.002, p = 0.04, p = 0.002, respectively). Fitness evaluation, health evaluation and body areas satisfaction scores of the MBSRQ were significantly different in the three groups (p = 0.003, p = 0.009 and p = 0.001, respectively). In this study, patients with CD were found to have lower QoL, lower body image perception and higher levels of depression compared to healthy controls, particularly if the disease is persistant despite surgery.
Literature
1.
go back to reference Bertagna X, Guignat L, Groussin L, Bertherat J (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623CrossRefPubMed Bertagna X, Guignat L, Groussin L, Bertherat J (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623CrossRefPubMed
2.
go back to reference Pivonello R, De Leo MC, De Leo M, Lombardi G, Colao A (2008) Cushing’s Syndrome. Endocrinol Metab Clin N Am 37:135–149CrossRef Pivonello R, De Leo MC, De Leo M, Lombardi G, Colao A (2008) Cushing’s Syndrome. Endocrinol Metab Clin N Am 37:135–149CrossRef
3.
go back to reference Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Müler OA, Fahlbusch R (2008) Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg 108:9–18CrossRefPubMed Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Müler OA, Fahlbusch R (2008) Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg 108:9–18CrossRefPubMed
4.
go back to reference Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L, Laws ER (2008) Late recurrences of Cushing’s disease after ınitial successful transsphenoidal surgery. J Clin Endocrinol Metab 93:358–362CrossRefPubMed Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L, Laws ER (2008) Late recurrences of Cushing’s disease after ınitial successful transsphenoidal surgery. J Clin Endocrinol Metab 93:358–362CrossRefPubMed
5.
go back to reference Mancini T, Porcelli T, Giustina A (2010) Treatment of Cushing’s disease: overview and recent findings. Ther Clin Risk Manag 6:505–516PubMed Mancini T, Porcelli T, Giustina A (2010) Treatment of Cushing’s disease: overview and recent findings. Ther Clin Risk Manag 6:505–516PubMed
6.
go back to reference Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F (1998) Clinical correlates of major depression in Cushing’s disease. Psychopathology 31:302–306CrossRefPubMed Sonino N, Fava GA, Raffi AR, Boscaro M, Fallo F (1998) Clinical correlates of major depression in Cushing’s disease. Psychopathology 31:302–306CrossRefPubMed
7.
go back to reference Sonino N, Fava GA (1998) Psychosomatic aspects of Cushing’s disease. Psychother Psychosom 67:140–146CrossRefPubMed Sonino N, Fava GA (1998) Psychosomatic aspects of Cushing’s disease. Psychother Psychosom 67:140–146CrossRefPubMed
8.
go back to reference Van Aken MO, Pereira AM, Biermasz NR, Van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SWJ, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing’s disease. J Clin Endocrinol Metab 90:3279–3286CrossRefPubMed Van Aken MO, Pereira AM, Biermasz NR, Van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SWJ, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing’s disease. J Clin Endocrinol Metab 90:3279–3286CrossRefPubMed
9.
go back to reference Sonino N, Fallo F, Fava GA (2010) Psychosomatic aspects of Cushing’s disease. Rev Endocr Metab Disord 11:95–104CrossRefPubMed Sonino N, Fallo F, Fava GA (2010) Psychosomatic aspects of Cushing’s disease. Rev Endocr Metab Disord 11:95–104CrossRefPubMed
10.
go back to reference Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman KL (2006) Long-term ımpaired quality of life in Cushing’s syndrome despite ınitial ımprovement after surgical remission. J Clin Endocrinol Metab 91:447–453CrossRefPubMed Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman KL (2006) Long-term ımpaired quality of life in Cushing’s syndrome despite ınitial ımprovement after surgical remission. J Clin Endocrinol Metab 91:447–453CrossRefPubMed
11.
go back to reference Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC (2007) Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing’s disease: a 10-Year experience. Ann Surg 245:790–794CrossRefPubMed Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC (2007) Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing’s disease: a 10-Year experience. Ann Surg 245:790–794CrossRefPubMed
12.
go back to reference Sonino N, Fava GA (1998) Psychological aspects of endocrine disease. Clin Endocrinol (Oxf) 49:1–7CrossRef Sonino N, Fava GA (1998) Psychological aspects of endocrine disease. Clin Endocrinol (Oxf) 49:1–7CrossRef
13.
go back to reference Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing’s disease. Clin Endocrinol (Oxf) 61:458–465CrossRef Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing’s disease. Clin Endocrinol (Oxf) 61:458–465CrossRef
14.
go back to reference Kelly WF (1996) Psychiatric aspects of Cushing’s syndrome. Q J Med 89:543–551CrossRef Kelly WF (1996) Psychiatric aspects of Cushing’s syndrome. Q J Med 89:543–551CrossRef
15.
go back to reference Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, Van Aken MO, Pivonello R, Stalla G, Lamberts SWJ, Glusman JE (2008) Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire. Eur J Endocrinol 58:623–630CrossRef Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, Van Aken MO, Pivonello R, Stalla G, Lamberts SWJ, Glusman JE (2008) Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire. Eur J Endocrinol 58:623–630CrossRef
16.
go back to reference Bech P, Gudex C, Staehr Johansen K (1996) The WHO (ten) well-being index: validation in diabetes. Psychother Psychosom 65:183–190CrossRefPubMed Bech P, Gudex C, Staehr Johansen K (1996) The WHO (ten) well-being index: validation in diabetes. Psychother Psychosom 65:183–190CrossRefPubMed
18.
go back to reference Nieman LK, Biler BMK, Findling JW, Newell Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526–1540CrossRefPubMed Nieman LK, Biler BMK, Findling JW, Newell Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526–1540CrossRefPubMed
19.
go back to reference Beck AT, Ward Ch, Mendelson M, Mosk J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed Beck AT, Ward Ch, Mendelson M, Mosk J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571CrossRefPubMed
20.
go back to reference Cohen SI (1980) Cushing’s syndrome: a psychiatric study of 29 patients. Br J Psychiatry 136:120–124CrossRefPubMed Cohen SI (1980) Cushing’s syndrome: a psychiatric study of 29 patients. Br J Psychiatry 136:120–124CrossRefPubMed
21.
go back to reference Loosen PT, Chamliss B, Debold CR, Shelton R, Orth DN (1992) Psychiatric phenomenology in Cushing’s disease. Pharmacopsychiatry 25:192–198CrossRefPubMed Loosen PT, Chamliss B, Debold CR, Shelton R, Orth DN (1992) Psychiatric phenomenology in Cushing’s disease. Pharmacopsychiatry 25:192–198CrossRefPubMed
22.
go back to reference Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M (1998) Risk factors and long term outcome in pituitary-dependent Cushing’s disease. Psychother Psychosom 67:140–146CrossRefPubMed Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M (1998) Risk factors and long term outcome in pituitary-dependent Cushing’s disease. Psychother Psychosom 67:140–146CrossRefPubMed
23.
go back to reference Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing’s syndrome. CNS Drugs 15:361–373CrossRefPubMed Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing’s syndrome. CNS Drugs 15:361–373CrossRefPubMed
24.
go back to reference Kelly WF, Checkley SA, Bender DA (1980) Cushing’s syndrome, tryptophan and depression. Br J Psychiatry 136:125–132CrossRefPubMed Kelly WF, Checkley SA, Bender DA (1980) Cushing’s syndrome, tryptophan and depression. Br J Psychiatry 136:125–132CrossRefPubMed
25.
go back to reference Tiemensma J, Biermasz NR, van der Mast RC, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing’s disease. J Clin Endocrinol Metab 95(12):E129–E141CrossRefPubMed Tiemensma J, Biermasz NR, van der Mast RC, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing’s disease. J Clin Endocrinol Metab 95(12):E129–E141CrossRefPubMed
26.
go back to reference Jeffcoate WJ, Silverstone JT, Edwars CR, Beser GM (1979) Psychiatric manifestations of Cushing’s syndrome: response to lowering of plasma cortisol. Q J Med 48:465–472PubMed Jeffcoate WJ, Silverstone JT, Edwars CR, Beser GM (1979) Psychiatric manifestations of Cushing’s syndrome: response to lowering of plasma cortisol. Q J Med 48:465–472PubMed
27.
go back to reference Castinetti F, Fassnacht M, Johanssen S, Terzolo M, Bouchard P, Chanson P, Do Cao C, Morange I, Pico A, Ouzounian S, Young J, Hahner S, Brue T, Allolio B, Conte-Devolx B (2009) Merits and pitfalls of mifepristone in Cushing’s syndrome. Eur J Endocrinol 160:1003–1010CrossRefPubMed Castinetti F, Fassnacht M, Johanssen S, Terzolo M, Bouchard P, Chanson P, Do Cao C, Morange I, Pico A, Ouzounian S, Young J, Hahner S, Brue T, Allolio B, Conte-Devolx B (2009) Merits and pitfalls of mifepristone in Cushing’s syndrome. Eur J Endocrinol 160:1003–1010CrossRefPubMed
28.
go back to reference Starkman MN, Schteingart DE, Schork MA (1986) Cushing’s syndrome after treatment: changes in cortisol and ACTH levels and amelioration of the depressive syndrome. Psychiatry Res 19:177–188CrossRefPubMed Starkman MN, Schteingart DE, Schork MA (1986) Cushing’s syndrome after treatment: changes in cortisol and ACTH levels and amelioration of the depressive syndrome. Psychiatry Res 19:177–188CrossRefPubMed
29.
go back to reference Dorn LD, Burgess ES, Friedman T, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing’s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912–919CrossRefPubMed Dorn LD, Burgess ES, Friedman T, Dubbert B, Gold PW, Chrousos GP (1997) The longitudinal course of psychopathology in Cushing’s syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912–919CrossRefPubMed
30.
go back to reference Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA (2006) Personality characteristics and quality of life in patients treated for Cushing’s syndrome. Clin Endocrinol 64:314–318CrossRef Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA (2006) Personality characteristics and quality of life in patients treated for Cushing’s syndrome. Clin Endocrinol 64:314–318CrossRef
31.
go back to reference Van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, Van Aken MO, Havekes B, Pereira AM, Pijl H, Smit JW, Romijn JA (2008) Disease specific impairments in quality of life during long term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) 69:775–784CrossRef Van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, Van Aken MO, Havekes B, Pereira AM, Pijl H, Smit JW, Romijn JA (2008) Disease specific impairments in quality of life during long term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) 69:775–784CrossRef
32.
go back to reference Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with pituitary adenoma. Pituitary 6:81–87CrossRefPubMed Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with pituitary adenoma. Pituitary 6:81–87CrossRefPubMed
33.
go back to reference Lindholm J, Juul S, Jorgenson JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing’s syndrome: a population –based study. J Clin Endocrinol Metab 86:117–123CrossRefPubMed Lindholm J, Juul S, Jorgenson JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing’s syndrome: a population –based study. J Clin Endocrinol Metab 86:117–123CrossRefPubMed
34.
go back to reference Hawn MT, Cook D, Deveney C, Sheppard BC (2002) Quality of life after bilateral adrenalectomy for Cushing’s disease. Surgery 132:1064–1068CrossRefPubMed Hawn MT, Cook D, Deveney C, Sheppard BC (2002) Quality of life after bilateral adrenalectomy for Cushing’s disease. Surgery 132:1064–1068CrossRefPubMed
35.
go back to reference Tiemensma J, Daskalakis NP, van der Veen EM, Ramondt S, Richardson SK, Broadbent E, Romijn JA, Pereira AM, Biermasz NR, Kaptein AA (2012) Drawings reflect a new dimension of the psychological ımpact of long-term remission of Cushing’s syndrome. J Clin Endocrinol Metab. (Epub ahead of print) Tiemensma J, Daskalakis NP, van der Veen EM, Ramondt S, Richardson SK, Broadbent E, Romijn JA, Pereira AM, Biermasz NR, Kaptein AA (2012) Drawings reflect a new dimension of the psychological ımpact of long-term remission of Cushing’s syndrome. J Clin Endocrinol Metab. (Epub ahead of print)
Metadata
Title
Evaluation of depression, quality of life and body image in patients with Cushing’s disease
Authors
Nilufer Alcalar
Sedat Ozkan
Pinar Kadioglu
Ozlem Celik
Penbe Cagatay
Baris Kucukyuruk
Nurperi Gazioglu
Publication date
01-09-2013
Publisher
Springer US
Published in
Pituitary / Issue 3/2013
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-012-0425-5

Other articles of this Issue 3/2013

Pituitary 3/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.